~~<i id='503CCDA2E2'><strike id='503CCDA2E2'><tt id='503CCDA2E2'><pre id='503CCDA2E2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：leisure time 2025-09-29 21:26:17 - browse：54656

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Pharma’s losing bet in New Jersey

entertainment

hotspot

entertainment

AcleaningcrewwearingprotectiveclothingtakesdisinfectingequipmentintoanursinghomeintheSeattlesuburbsf

WSS

WATCH: Why do bright lights make us see spots?

How housing is health care on Long Island

Walmart eyes Medicare Advantage provider ChenMed

U.S. death rates show how politics are affecting public health

Hospitals consider fixing cancer drug shortages on their own

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

explore

explore

entertainment

Moonlake's readout produced a cash windfall. Risks remain

Some medical students still think black patients feel less pain

Medical leaders decry Supreme Court decision on affirmative action

Hospitals need to get ahead of regulations on climate change

Trump demands the U.S. pay no more for drugs than other countries … again

Should insurance cover cosmetic surgery?

The cancer drug shortage isn’t new — and neither are the solutions

New research sheds light on how often breast cancer is overdiagnosed

Wildfire smoke exposes gaps in outdoor worker protections

Diverse clinical trials: Why aren’t we there yet?

hotspot

Pharma’s losing bet in New Jersey

Beyond aggravation: Constipation is an American epidemic

Will the IRA bring competition to the biologics market?

Decentralized clinical trials need collaboration to achieve wider use

Unmasking the 'centricity' illusion in clinical trials

The world needs the new pandemic treaty

hotspot

hotspot

entertainment

entertainment